Understanding cognitive outcomes after stroke
Official title: StrokeCog-BBB to Study Cognitive Outcomes Following Stroke
Run by Stanford University · NCT06116630 · Data updated 2026-11-12
This study looks at how a stroke affects thinking and memory over time in stroke patients compared to people with similar heart risks, to see if certain blood markers can help predict cognitive decline.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 90 Years |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | May 17, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 18, 2024 |
| Trial ID | NCT06116630 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 45 and older with one or more vascular risk factors who have not experienced a stroke or significant brain injury.
✕Probably not a fit
Patients with a history of stroke, dementia, or major neurological diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate cognitive outcomes in stroke patients by examining the long-term effects of stroke on brain function. Researchers will assess blood-brain barrier permeability, identify blood biomarkers related to angiogenesis, and explore their relationship with cognitive decline. Participants will undergo cognitive testing and MRIs two years apart, and their outcomes will be compared to non-stroke patients with cardiovascular risk factors. The study seeks to uncover potential mechanisms behind post-stroke dementia and establish biomarkers for predicting cognitive decline.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and early identification of patients at risk for cognitive decline after a stroke.
How similar studies have gone: While there is ongoing research into post-stroke cognitive outcomes, this study's specific focus on blood-brain barrier dysfunction and biomarkers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 45 years or over * One or more vascular risk factors (e.g. high blood pressure, diabetes or vascular disease such as angina, a previous heart attack, a heart bypass or peripheral artery disease in the legs) * Established vascular disease (previous MI, angina, vascular stent in the peripheral bed) * Sufficiently fluent in written and spoken English * Living independently in the community * Willing/able to give consent to study participation. Exclusion Criteria: * Current treatment with IL-1 blockade or established immune-suppressant therapy (e.g. IL-1Ra or IL-1 antibodies), or treatment within the last 3 months * Currently participating in a clinical trial of investigation medicinal product (CTIMP) or device trial. * No history of any previous ischaemic or haemorrhagic stroke, a mini-stroke or a serious brain injury * Do not have dementia * Renovascular Disease * Major neurological disease (immune mediated, previous brain tumors)
Where it's running
-
Stanford University Hospital
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: Marion Buckwalter, MD — Stanford University
- Study coordinator: Muhith Musabbir
- Email: musabbir@stanford.edu
- Phone: 650-723-8886
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.